½ÃÀ庸°í¼­
»óǰÄÚµå
1362461

¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, Áö¿ªº° Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® º¸°í¼­ ¹üÀ§ : ±¸¼º ¿ä¼Òº°, ¹èÄ¡º°, ¾à±¹ ±Ô¸ðº°, ÃÖÁ¾ »ç¿ëÀÚº°

US Pharmacy Management System Market Size and Forecasts, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Component, Deployment, Size of Pharmacies, End User

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 78 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

´ç»çÀÇ ÃֽŠÁ¶»ç º¸°í¼­ "¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, Áö¿ªº° Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® º¸°í¼­ ¹üÀ§ : ±¸¼º ¿ä¼Òº°, ¹èÄ¡º°, ¾à±¹ ±Ô¸ðº°, ÃÖÁ¾ »ç¿ëÀÚº°"¿¡ µû¸£¸é 2022³â ½ÃÀå ±Ô¸ð´Â 210¾ï 1,759¸¸ ´Þ·¯, 2030³â¿¡´Â 53¾ï 1,100¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2022-2030³â°£ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 12.29%·Î Ãß»êµË´Ï´Ù.

¾à±¹ °ü¸® ¼ÒÇÁÆ®¿þ¾î´Â ¾à±¹¿¡¼­ »ç¿ëÇÏ´Â ½Ã½ºÅÛÀ¸·Î ¿öÅ©Ç÷οìÀÇ ÀÚµ¿È­¸¦ Áö¿øÇÏ´Â ½Ã½ºÅÛÀÔ´Ï´Ù. ÀǾàǰ ÁÖ¹® ¹× Àç°í °ü¸®, ÀÇ»ç ÁÖ¹® È®ÀÎ ¹× ÀǾàǰ Áغñ, º¸Çè ¹× Ã»±¸ ó¸®, ºÎÀûÇÕ È®ÀÎ, »ó´ã Á¦°ø µîÀ» Æ÷ÇÔÇϸç, ¹ýÀû ÇÁ·ÎÅäÄÝ ¹× ±ÔÁ¤ Áؼö¸¦ µû¶ó¾ß ÇÕ´Ï´Ù. ¾à±¹ ¾÷¹«ÀÇ º¹À⼺ Áõ°¡·Î ÀÎÇÑ ÀÚµ¿È­ ÇÁ·Î¼¼½º·ÎÀÇ Àüȯ°ú ¾à±¹ °ü¸®¿¡ ÁýÁßÇÏ´Â µ¶¸³ ¾à±¹ÀÌ Áõ°¡Çϸ鼭 ½Ã¼ú Æ®·¹ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼Ò¸Å ¾à±¹ÀÇ ´Ù¾çÈ­´Â ÇâÈÄ ¸î ³âµ¿¾È ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ì±¹¿¡¼­´Â ¼Ò¸Å ¾à±¹Àº °í°´ÀÇ ½Å·Ú¿Í Ã¥ÀÓÀ» ´ã´çÇϰí ÀÖÀ¸¸ç, ÇコÄÉ¾î ºÐ¾ß¿¡¼­ Áß¿äÇÑ ¼Ò¸Å »ç¾÷ÀÔ´Ï´Ù. Çõ½ÅÀûÀÎ POS ½Ã½ºÅÛÀÎ ¼Ò¸Å ¾à±¹ ¼ÒÇÁÆ®¿þ¾î´Â Àç°í¸¦ ÃÖÀûÈ­ÇÏ°í °í°´ Ãæ¼ºµµ ÇÁ·Î±×·¥À» °ü¸®Çϸç Á¤È®ÇÑ º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. µ¥ÀÌÅͰ¡ ¼Ò¸Å ¾à±¹ÀÇ °¡Àå Áß¿äÇÑ ºÎºÐÀÌ µÇ°í ÀÖ°í °í°´ ÇൿÀ» ¸ÅÇÎÇÏ´Â µ¥ Á¡Á¡ ´õ ¸¹Àº °ü½ÉÀ» ±â¿ïÀ̰í Àֱ⠶§¹®¿¡ ÀÌ Ã·´Ü ±â¼úÀº ÇâÈÄ ¸î³â¾È¿¡ ´ëºÎºÐÀÇ ÀüÅëÀûÀÎ ¼öÀÛ¾÷ ¾à±¹ ¹æ½ÄÀ» ´ëüÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ, ¼Ò¸Å ¾à±¹¿ë ¼ÒÇÁÆ®¿þ¾î´Â ÃÖÁ¾ »ç¿ëÀÚ°¡ ´õ ³ªÀº ÀÓ»óÀû, ÀçÁ¤Àû, ¾÷¹«Àû ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Á¤È®ÇÑ ÅëÂû·Â°ú Æò°¡¸¦ °áÇÕÇÏ¿© Á¦°øÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

ÁöºÒÀÚ, ÀÇ·á Á¦°ø¾÷ü ¹× ¹ÙÀÌ¿À Á¦¾à ȸ»ç´Â °Ç°­ °ÝÂ÷ ÇØ¼Ò¸¦ À§ÇÑ ÀÌ´Ï¼ÅÆ¼ºê¸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù. ¼Ò¸Å ¾à±¹Àº Áö¿ª ¹ÐÂøÇüÀ̱⠶§¹®¿¡ º¸´Ù °øÆòÇÑ Ä¡·á¸¦ Á¦°øÇϱ⠽±´Ù. ZS´Â ÇØ¸®½º Æú°ú ÇÔ²² ½Ç½ÃÇÑ Á¶»ç¿¡¼­ ¹Ì±¹¿¡¼­ °Ç°­ º¸Çè¿¡ °¡ÀÔÇÏÁö ¾ÊÀº ȯÀÚ°¡ 1Â÷ Áø·á¸¦ À§ÇØ ¾à±¹À» ¼±ÅÃÇÒ °¡´É¼ºÀÌ °¡Àå ³ô´Ù´Â °ÍÀ» ¹ß°ßÇß½À´Ï´Ù. ¶ÇÇÑ ¹Ì±¹ ¼Ò¸Å ¾à±¹ ¾÷°è´Â ±âŸ ±¹°¡¿¡ ºñÇØ ÀüÀÚ»ó°Å·¡ µµÀÔÀÌ µÚÃÄÁ® ÀÖ½À´Ï´Ù. ÇÏÁö¸¸ Äڷγª19 »çÅ·ΠÀÎÇØ ÀçÅà ¾à±¹ Áø·á¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼±È£µµ°¡ ±ÞÁõÇß°í, ÀÌ·¯ÇÑ Ãß¼¼´Â ¾ÕÀ¸·Îµµ Áö¼ÓµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹¿¡¼­´Â ¾Æ¸¶Á¸ÀÌ Çö±ÝÀ̳ª º¸ÇèÀ» ÅëÇØ 󹿾àÀ» ¿Â¶óÀÎÀ¸·Î ±¸¸ÅÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. ÀÌó·³ ¼Ò¸Å ¾à±¹ÀÇ ÁøÈ­´Â ÇâÈÄ ¸î ³âµ¿¾È ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå°¡ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¹èÄ¡º° ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå ±â¹Ý ÀλçÀÌÆ®

¹èÄ¡¸¦ ±âÁØÀ¸·Î ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº Ŭ¶ó¿ìµå ±â¹Ý°ú ¿ÂÇÁ·¹¹Ì½º·Î ±¸ºÐµË´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®Àº 2022³â Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022-2030³â 13.06%ÀÇ ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¹èÆ÷´Â ȯÀÚ µ¥ÀÌÅ͸¦ °ü¸®ÇÒ ¼ö ÀÖ´Â º¸´Ù ¾ÈÀüÇϰí Ç¥ÁØÈ­µÈ Á¤º¸ ½Ã½ºÅÛÀ» Á¦°øÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¾à±¹ °ü¸® ½Ã½ºÅÛÀº ÀÎÅͳÝÀ̳ª À¥ ºê¶ó¿ìÀú¸¦ ÅëÇØ ÄÄÇ»ÅÍ¿¡ ¿¬°áÇÒ ¼ö Àֱ⠶§¹®¿¡ ¾ðÁ¦ ¾îµð¼­³ª ´Ù¾çÇÑ ÀåÄ¡¿¡¼­ µ¥ÀÌÅÍ¿¡ ¾×¼¼½º ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº »ó¾÷ ¹× Çмú ±â°ü¿¡ »ùÇà °Ë»ç, Àåºñ »ç¿ë, ÀÚµ¿È­ ¹× º¸°í¿¡¼­ »ý¼ºµÈ ½ÇÇè½Ç µ¥ÀÌÅ͸¦ °ü¸®ÇÒ ¼ö Àִ ǥÁØÈ­µÈ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, °ü¸®Çϱ⠽±°í, ¾àǰ Àç°í, °ü¸® Á÷¿ø, ÀÇ»ç ó¹æÀü, ÀÇ·á Àç°í º¸Ãæ µî¿¡ ´ëÇÑ ½Ç½Ã°£ Á¤º¸¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.

¾à±¹ ±Ô¸ðº°, ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå ÀλçÀÌÆ®

¾à±¹ ±Ô¸ð¿¡ µû¶ó ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº Áß¼ÒÇü ¾à±¹°ú ´ëÇü ¾à±¹À¸·Î ±¸ºÐµÇ¸ç, 2022³â ½ÃÀå Á¡À¯À²Àº ´ëÇü ¾à±¹ÀÌ ´õ Å©°í 2022-2030³â°£ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº Áß¼ÒÇü ¾à±¹ÀÌ 13.22%·Î ¿¹ÃøµË´Ï´Ù. ÀÇ·á ½Ã½ºÅÛ°ú ¼ÒºñÀÚ ÇൿÀÇ ±Þ°ÝÇÑ º¯È­·Î ÀÎÇØ ¾à±¹Àº ¼Ò±Ô¸ð Á¶Á¦ ¾à±¹¿¡¼­ À£ºù ¼¾ÅÍ·Î ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. µðÁöÅÐÈ­´Â ¼öÀÛ¾÷À» ¾ø¾Ö´Â µ¥ Å« ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ¾à±¹Àº °í°´°ú ÀǾàǰ °ø±ÞÀÚ¿¡°Ô ÇýÅÃÀ» ÁÖ´Â Çõ½ÅÀûÀÎ Àü·«À» µµÀÔÇÏ¿© ºñÁî´Ï½º °³¼±¿¡ ÀÚ¿øÀ» ÅõÀÔÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. °í°´ °ü¸® ½Ã½ºÅÛÀº Áß¼Ò±Ô¸ðÀÇ ¾à±¹ ºñÁî´Ï½º¿¡¼­ ÇʼöÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î ÀÔÁõµÇ¾ú½À´Ï´Ù. ¸Å·ÂÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º¸¦ °®Ãß°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Å½»öÀÌ ½±°í ȯÀÚ ¸ñ·ÏÀ» ÀÚµ¿À¸·Î ¾÷µ¥ÀÌÆ®ÇÕ´Ï´Ù. ¶ÇÇÑ ¾à»ç°¡ ¼Õ³¡¿¡¼­ Á¤º¸¿¡ ¾×¼¼½ºÇÏ°í ¼ö¸¹Àº ȯÀÚ ÇÁ·ÎÆÄÀÏÀ» °ü¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼¼°èº¸°Ç±â±¸(WHO), ±¹°¡Ã³¹æ¾à¹°ÇÁ·Î±×·¥ÇùÀÇȸ(National Council for Prescription Drugs Programs), Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ(Centers for Disease Control and Prevention, CDC) µîÀº ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå º¸°í¼­¸¦ ÀÛ¼ºÇÒ ¶§ Âü°íÇÑ ÁÖ¿ä 1Â÷ ¹× 2Â÷ Á¤º¸ Áß ÀϺÎÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦3Àå ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå - ½ÃÀå ±¸µµ

    • ¹Ì±¹ PEST ºÐ¼®

Á¦4Àå ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå - ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ÇâÈÄ µ¿Çâ
  • ¿µÇ⠺м®

Á¦5Àå ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå : ±¹°¡º° ºÐ¼®

Á¦6Àå ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå - 2030³â±îÁö ¸ÅÃâ°ú ¿¹Ãø-ÄÄÆ÷³ÍÆ®º°

  • ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå 2022³â¡¤2030³â ÄÄÆ÷³ÍÆ®º° ÆÇ¸Å·® Á¡À¯À²(%)
  • ¼Ö·ç¼Ç
  • ¼­ºñ½º

Á¦7Àå ¾à±¹ °ü¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå : ¸ÅÃâ°ú 2030³â±îÁö ¿¹Ãø : Àü°³ Çüź°

  • ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå : 2022³â¡¤2030³â Àü°³ Çüź° ÆÇ¸Å·® Á¡À¯À²(%)
  • Ŭ¶ó¿ìµå ±â¹Ý
  • ¿ÂÇÁ·¹¹Ì½º

Á¦8Àå ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå - 2030³â±îÁö ¸ÅÃâ°ú ¿¹Ãø : ¾à±¹ ±Ô¸ðº°

  • ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå : 2022³â¡¤2030³â ¾à±¹ ±Ô¸ðº° ÆÇ¸Å·® Á¡À¯À²(%)
  • Áß¼Ò±Ô¸ð ¾à±¹
  • ´ë±Ô¸ð ¾à±¹

Á¦9Àå ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå - 2030³â±îÁö ¸ÅÃâ°ú ¿¹Ãø-ÃÖÁ¾»ç¿ëÀÚº°

  • ¹Ì±¹ÀÇ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå 2022³â¡¤2030³â ÃÖÁ¾»ç¿ëÀÚº° ÆÇ¸Å·® Á¡À¯À²(%)
  • ÀÔ¿ø ȯÀÚ ¾à±¹
  • ¿Ü·¡ ȯÀÚ ¾à±¹

Á¦10Àå ¾÷°è »óȲ

  • À¯±âÀû ¼ºÀå Àü·«
  • ¹«±âÀû ¼ºÀå Àü·«

Á¦11Àå ±â¾÷ °³¿ä

  • McKesson Corp
  • Becton Dickinson and Co
  • Veradigm Inc.
  • Epicor Software Corp
  • Swisslog Healthcare AG
  • Omnicell Inc
  • CPS Solutions LLC
  • RedSail Technologies LLC
  • Micro Merchant Systems Inc
  • Oracle Corp

Á¦12Àå ºÎ·Ï

LSH 23.10.24

According to our new research study on " US Pharmacy Management System Market Forecasts (2020 - 2030), Country Share, Trends, and Growth Opportunity Analysis - by Component, Deployment, Size of Pharmacies, and End User," the market was valued at US$ 21,017.59 million in 2022 and is expected to reach US$ 53,139.59 million by 2030. It is estimated to register a CAGR of 12.29% during 2022-2030.

A pharmacy management software is any system used in a pharmacy that helps to automate the workflow. It includes making drug orders and controlling the inventory, reviewing physician orders and preparing medications, handling insurance and billing, identifying incompatibilities, providing counseling, and others while following the legal protocols and compliances. An inclination toward automated processes with surging complexity of pharmacy operations and the rising number of independent pharmacies focused on pharmacy management drive the growth of the procedure trays market. Also, diversification of retail pharmacies is expected to fuel pharmacy management system market growth in the coming years.

In the US, retail pharmacies are important retail businesses in the healthcare sector as they hold the trust and responsibility of customers. Retail pharmacy software, an innovative POS system, can optimize inventory, manage customer loyalty programs, and provide accurate reporting. With data becoming the most important part of retail pharmacy and increasing focus on mapping customers' behavior, this advanced technology would replace most traditional manual pharmacy methods in the coming years. Retail pharmacy software is also likely to provide a combination of precise insights and assessments, which would help end users make better clinical, financial, and operational decisions.

Payers, providers, and biopharma companies are introducing initiatives to address health disparities. Retail pharmacies are closer to communities, making it easy for them to provide more equitable care. In a study conducted in cooperation with the Harris Poll, ZS found that patients without health insurance are most likely to choose a pharmacy for primary care in the US. Also, the US retail pharmacy industry lags behind other countries in terms of the adoption of e-commerce. Nevertheless, it experienced a surge in consumer preference for in-home pharmacy care during the COVID-19 pandemic, and the trend is likely to continue in the coming years. For instance, in the US, Amazon allows customers to buy prescription medications online using cash or insurance coverage. Thus, evolving retail pharmacy would lead to new trends in the US pharmacy management system market in the coming years.

By Deployment, US Pharmacy Management System Market-Based Insights

Based on deployment, the US pharmacy management system market is segmented into cloud-based and on-premise. The cloud-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 13.06% during 2022-2030. Cloud-based deployment offers a safer and more standardized information system to manage patient data. Cloud-based pharmacy management systems can be connected to computers via the internet and web browser, which enables access to the data anytime and anywhere, on different devices. These systems offer a standardized way to help commercial and academic institutions manage laboratory data generated from sample testing, instrument usage, automation, and report generation. Moreover, they are easy to manage and helps users access real-time information regarding drug inventory, administrative staff, doctor's prescriptions, medical stock refills, etc.

By Size of Pharmacies, Pharmacy Management System Market -Based Insights

Based on the size of pharmacies, the US pharmacy management system market is segmented into small- and medium-sized pharmacies, and large pharmacies. The large pharmacies segment held a larger market share in 2022, and the small- and medium-sized pharmacies segment is anticipated to register a higher CAGR of 13.22% during 2022-2030. Rapid changes in healthcare systems and consumer behavior propel pharmacies to evolve from small medical dispensaries to well-being centers. Digitalization has played a major role in eliminating manual tasks, allowing pharmacies to invest resources into improving their businesses by incorporating innovative strategies that benefit customers and drug suppliers. A customer management system has proven to be a vital solution in small and medium-sized pharmacy businesses. It has an attractive, user-friendly interface. The system also provides easy navigation and automatically refreshes the patient's list. Additionally, it allows pharmacists to access information and manage numerous patient profiles at their fingertips.

The World Health Organization (WHO), National Council for Prescription Drug Programs, Centers for Disease Control and Prevention (CDC) are a few of the major primary and secondary sources referred to while preparing the report on the US pharmacy management system market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the US Pharmacy Management System Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the US Pharmacy Management System Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Research Methodology

  • 2.1 Coverage
  • 2.2 Secondary Research
  • 2.3 Primary Research

3. US Pharmacy Management System Market - Market Landscape

  • 3.1 Overview
    • 3.1.1 US PEST Analysis

4. US Pharmacy Management System Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Inclination Toward Automated Processes with Surging Complexity of Pharmacy Operations
    • 4.1.2 Rising Number of Independent Pharmacies Focused on Pharmacy Management
  • 4.2 Market Restraints
    • 4.2.1 Cybersecurity Issues and Operational Limitations of Pharmacy Management Systems
  • 4.3 Market Opportunities
    • 4.3.1 Transformation of Retail Pharmacy into Advanced Patient Care
  • 4.4 Future Trends
    • 4.4.1 Diversification of Retail Pharmacies
  • 4.5 Impact Analysis

5. US Pharmacy Management System Market - Country Analysis

  • 5.1 US Pharmacy Management System Market
    • 5.1.1 Overview

6. Pharmacy Management System Market - Revenue and Forecast to 2030 - by Component

  • 6.1 Overview
  • 6.2 US Pharmacy Management System Market Revenue Share, by Component 2022 & 2030 (%)
  • 6.3 Solutions
    • 6.3.1 Overview
    • 6.3.2 Solution: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 EMR/EHR
        • 6.3.2.1.1 Overview
        • 6.3.2.1.2 EMR/EHR: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.2 Inventory Management
        • 6.3.2.2.1 Overview
        • 6.3.2.2.2 Inventory Management: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.3 Purchase Order Management
        • 6.3.2.3.1 Overview
        • 6.3.2.3.2 Purchase Order Management: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.4 Supply Chain Management
        • 6.3.2.4.1 Overview
        • 6.3.2.4.2 Supply Chain Management: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.5 Regulatory and Compliance Information
        • 6.3.2.5.1 Overview
        • 6.3.2.5.2 Regulatory and Compliance Information: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.6 Clinical Pharmacy Management
        • 6.3.2.6.1 Overview
        • 6.3.2.6.2 Clinical Pharmacy Management: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.7 Others
        • 6.3.2.7.1 Overview
        • 6.3.2.7.2 Others: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Services
    • 6.4.1 Overview
    • 6.4.2 Services: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)

7. Global US Pharmacy Management System Market - Revenue and Forecast to 2030 - by Deployment

  • 7.1 Overview
  • 7.2 US Pharmacy Management System Market Revenue Share, by Deployment 2022 & 2030 (%)
  • 7.3 Cloud-based
    • 7.3.1 Overview
    • 7.3.2 Cloud-based: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 On-premise
    • 7.4.1 Overview
    • 7.4.2 On-premise: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)

8. Global US Pharmacy Management System Market - Revenue and Forecast to 2030 - by Size of Pharmacies

  • 8.1 Overview
  • 8.2 US Pharmacy Management System Market Revenue Share, by Size of Pharmacies 2022 & 2030 (%)
  • 8.3 Small and Medium-sized Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Small and Medium-sized Pharmacies: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Large Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Large Pharmacies: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)

9. Global US Pharmacy Management System Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 US Pharmacy Management System Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Inpatient Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Inpatient Pharmacies: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Outpatient Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Outpatient Pharmacies: US Pharmacy Management System Market - Revenue and Forecast to 2030 (US$ Million)

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Organic Growth Strategies
    • 10.2.1 Overview
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview

11. Company Profiles

  • 11.1 McKesson Corp
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Becton Dickinson and Co
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Veradigm Inc.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Epicor Software Corp
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Swisslog Healthcare AG
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Omnicell Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 CPS Solutions LLC
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 RedSail Technologies LLC
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Micro Merchant Systems Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Oracle Corp
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦